Department of Specialized Medicine, Digestive Pathophysiology Unit, Baggiovara Hospital, Modena, Italy.
Department of Pathophysiology and Transplantation, University of Milano.
Am J Gastroenterol. 2019 Oct;114(10):1606-1613. doi: 10.14309/ajg.0000000000000379.
Role of reflux and mechanisms of response to proton pump inhibitor (PPI) therapy in eosinophilic esophagitis (EoE) have not yet been fully elucidated. Comprehensive assessment by impedance-pH monitoring could clarify these issues.
Prospective multicenter study comparing EoE patients with healthy controls and gastroesophageal reflux disease cases. Patients with EoE were evaluated off- and on PPI; responsiveness was assessed by histology. Impedance-pH appraisal included chemical clearance, assessed with the postreflux swallow-induced peristaltic wave (PSPW) index, and mucosal integrity measured with mean nocturnal baseline impedance (MNBI).
Sixty consecutive patients with EoE were compared with 60 age- and sex-matched healthy controls and 60 subjects with gastroesophageal reflux disease. The number of total refluxes was higher, while the PSPW index was lower in patients with EoE than in healthy controls. Off PPI, a lower MNBI gradient between the mid and distal esophagus distinguished 20 patients with PPI-refractory EoE from 40 patients with PPI-responsive EoE and was a predictor of PPI failure. On PPI, a lower PSPW index was the sole reflux parameter distinguishing PPI-refractory from PPI-responsive EoE; all reflux parameters improved in PPI-responsive patients, whereas the PSPW index was not modified in PPI-refractory cases and was independently associated with PPI-responsiveness. MNBI in the distal and mid esophagus improved much more in PPI-responsive than in PPI-refractory EoE.
Reflux plays a role in the pathogenesis of EoE, more relevant in PPI-responsive cases. Low impedance gradient between the mid and distal esophagus may be useful to predict PPI refractoriness. PPIs mainly act by improving chemical clearance, i.e., by an antireflux action supporting long-term prescription in PPI-responsive EoE.
胃食管反流(GER)和质子泵抑制剂(PPI)治疗反应的机制在嗜酸性粒细胞性食管炎(EoE)中的作用尚未完全阐明。通过阻抗 pH 监测的综合评估可以阐明这些问题。
这是一项比较 EoE 患者与健康对照和胃食管反流病(GERD)患者的前瞻性多中心研究。对 EoE 患者进行 PPI 治疗前后的评估;通过组织学评估反应性。阻抗 pH 评估包括化学清除率,通过反流后吞咽诱导蠕动波(PSPW)指数评估,以及通过平均夜间基础阻抗(MNBI)评估黏膜完整性。
连续 60 例 EoE 患者与 60 例年龄和性别匹配的健康对照者和 60 例 GERD 患者进行比较。EoE 患者的总反流次数较高,而 PSPW 指数较低。在未服用 PPI 时,食管中下段 MNBI 梯度较低可将 20 例 PPI 难治性 EoE 患者与 40 例 PPI 反应性 EoE 患者区分开来,是 PPI 失败的预测因素。在服用 PPI 时,PSPW 指数是唯一可区分 PPI 难治性和 PPI 反应性 EoE 的反流参数;所有反流参数在 PPI 反应性患者中均得到改善,而 PSPW 指数在 PPI 难治性患者中未改变,且与 PPI 反应性独立相关。与 PPI 难治性 EoE 相比,PPI 反应性 EoE 患者的远端和中段食管 MNBI 改善更为明显。
反流在 EoE 的发病机制中起作用,在 PPI 反应性病例中更为相关。食管中下段阻抗梯度较低可能有助于预测 PPI 耐药性。PPI 主要通过改善化学清除率起作用,即通过抗反流作用支持 PPI 反应性 EoE 的长期处方。